Vice President, External Manufacturing

Working with Us Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible. Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more: careers.bms.com/working-with-us .

Summary The Vice President, External Manufacturing is a bold, transformative enterprise leader responsible for the strategic direction and operational execution of BMS's global external manufacturing network — spanning the full portfolio across Product Development and Supply (PDS). This role oversees a large and complex network of Contract Manufacturing Organizations (CMOs) and CDMOs that collectively underpin over $10 billion in annual BMS revenue. A defining mandate is to build and scale a fully integrated, seamless and efficient external network spanning clinical development through to commercial manufacturing, encompassing clinical manufacturing, tech transfer, process validation, and commercial readiness across a portfolio of strategically aligned CMO/CDMO partners. With accountability for a matrixed organization of 600+ employees across the US, Europe, and Asia, this leader sets and drives the external manufacturing strategy to ensure reliable, high-quality, cost-competitive supply of Biologics, Pharmaceutical, and Cell Therapy products in full alignment with BMS's enterprise supply chain goals, cGMP standards, and patient-first mission.

Strategy & Enterprise Vision Define and drive the long-term global external manufacturing strategy across BMS' portfolios, aligned with BMS's broader supply chain and enterprise priorities. Create a clinical development through commercial manufacturing operating model, integrating CDMOs for early-phase through to CMOs for late-stage and commercial production — strategically investing in partner excellence. Partner with Business Development, Portfolio Strategy, and Finance to align external manufacturing capacity to pipeline progression and commercial demand forecasts. Think 3–5 years ahead, developing contingency plans and strategic optionality in an increasingly complex global environment. Create integrated, long-term strategies with the potential to transform BMS and the broader biopharma and cell therapy industry. Digital Transformation - Own and drive the AI and digital strategy for the external manufacturing network – establishing BMS as an industry leader in AI-enabled partner orchestration and supply chain intelligence, Enable real-time, bidirectional data exchange with CMO/CDMO partners; leverage AI and advanced analytics to generate predictive insights on supply risk, quality trends, and operational performance across the network, with human-in-the-loop governance at critical decision gates. Establish an AI governance framework for the external manufacturing ecosystem – defining standards for model validation, data sharing agreements, IP protection, algorithmic transparency, and regulatory acceptability of AI-augmented decisions in GMP environments. Build the digital infrastructure and data architecture required to scale AI capabilities across 75+ external partners with varying levels of digital maturity. CMO/CDMO Network Management Provide comprehensive business, relationship, and operational oversight of 75+ external